» Articles » PMID: 17635024

Beta-tricalcium Phosphate Release from Brushite Cement Surface

Overview
Date 2007 Jul 20
PMID 17635024
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Different in vivo studies demonstrated that brushite cements are biocompatible, bioresorbable, and osteoconductive. However, the decay of brushite cements has been scarcely studied even though it may be of great concern for clinical applications in highly blood-perfused regions. This work was elaborated to elucidate factors that determine brushite cement surface disintegration. For that, brushite cements were modified using in their preparation different aqueous solutions of phosphoric, glycolic, tartaric, and citric acids in concentrations that were reported to improve the cement properties. Two-viscosity enhancing polysaccharides, chondroitin-4 sulfate and hyaluronic acid, were also assayed. Thereafter, pre- and set cement samples were immersed in distilled water for 24 h. The cement-solid weight loss, microstructure, liquid phase viscosity, mean size of the released particles, and zeta potential were analyzed using X-ray diffraction, FTIR spectroscopy, light scattering, scanning electron microscopy and optical microscopy. It was found that the particles released from the cement surface were beta-TCP, and their amount depends on the carboxylic acid used in the preparation of the cement. The addition of hyaluronic acid and chondroitin-4 sulfate decreased the amount of released particles from the surface of the set brushite cement made with citric acid. Furthermore, the hyaluronic acid increased significantly the viscosity of the citric acid solution and the cement paste prepared with this liquid phase showed a pronounced step down in particle release. In this study, we showed that the water solubility of calcium carboxylate and the viscosity of mixing liquid may dictate the superficial disintegration of brushite cements.

Citing Articles

Extra-short implants (≤ 6.5 mm in length) in atrophic and non-atrophic sites to support screw-retained full-arch restoration: a retrospective clinical study.

Anitua E, Eguia A, Alkhraisat M Int J Implant Dent. 2023; 9(1):29.

PMID: 37702800 PMC: 10499764. DOI: 10.1186/s40729-023-00499-7.


Bone-Regenerative Ability of Platelet-Rich Plasma Following Sinus Augmentation with Anorganic Bovine Bone: A Systematic Review with Meta-Analysis.

Anitua E, Allende M, Eguia A, Alkhraisat M Bioengineering (Basel). 2022; 9(10).

PMID: 36290564 PMC: 9598686. DOI: 10.3390/bioengineering9100597.


Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization.

Anitua E, Zalduendo M, Troya M, Alkhraisat M, Blanco-Antona L Int J Mol Sci. 2022; 23(12).

PMID: 35742995 PMC: 9223511. DOI: 10.3390/ijms23126552.


Short Narrow Dental Implants versus Long Narrow Dental Implants in Fixed Prostheses: A Prospective Clinical Study.

Antiua E, Escuer V, Alkhraisat M Dent J (Basel). 2022; 10(3).

PMID: 35323241 PMC: 8947067. DOI: 10.3390/dj10030039.


Factors influencing the drug release from calcium phosphate cements.

Fosca M, Rau J, Uskokovic V Bioact Mater. 2021; 7:341-363.

PMID: 34466737 PMC: 8379446. DOI: 10.1016/j.bioactmat.2021.05.032.